AWM
NVCR icon

AE Wealth Management’s NovoCure NVCR Stock Holding History

AE Wealth Management’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-2,012
Closed -$234K – 1758
2021
Q3 		$234K Sell
2,012
-1,588
-44% -$240K ﹤0.01% 1471
2021
Q2 		$799K Sell
3,600
-188
-5% -$36.6K 0.01% 921
2021
Q1 		$501K Sell
3,788
-6,823
-64% -$1.08M 0.01% 1031
2020
Q4 		$1.84M Buy
10,611
+8,413
+383% +$1.15M 0.02% 520
2020
Q3 		$245K Sell
2,198
-1,431
-39% -$114K ﹤0.01% 1108
2020
Q2 		$215K Buy
+3,629
New +$239K ﹤0.01% 1132

Other funds holding NVCR

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AE Wealth Management's NVCR Position: Q4 2021 in Review

AE Wealth Management sold out of NovoCure (NVCR) in Q4 2021, closing a stake of 2,012 shares — an estimated $234K sold.

AE Wealth Management first reported a position in NVCR in Q2 2020 and held it in 6 quarters. The position peaked at $1.84M in Q4 2020. 311 funds tracked by Wall St. Rank hold NVCR as of Q4 2021.

  • AE Wealth Management reported no remaining NovoCure position as of Q4 2021 after selling out during the quarter.
  • AE Wealth Management sold 2,012 NovoCure shares in Q4 2021, an estimated $234K.
  • AE Wealth Management first reported a position in NovoCure in Q2 2020 and held it in 6 quarters.
  • AE Wealth Management's NovoCure position peaked at $1.84M in Q4 2020.
  • 311 funds tracked by Wall St. Rank held NovoCure as of Q4 2021.

Based on AE Wealth Management's 13F filing for Q4 2021, filed 20 Jan 2022.